MEDIFMedipharm Labs Corporation

About Medipharm Labs Corporation (MEDIF)

Medipharm Labs Corporation (MEDIF) is a Drug Manufacturers - Specialty & Generic company headquartered in Barrie, ON, Canada whose shares trade over-the-counter on the OTCQB tier.

Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, MediPharm Labs formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment Licence from Health Canada, becoming the only company in North America to hold a domestic Good Manufacturing Licence for the extraction of natural cannabinoids. MediPharm carries out its operations in compliance with all applicable laws in the countries in which it operates.

Products and services

Cannabis extraction. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with primary extraction lines and finished formulated products capabilities used to deliver pure, trusted and precisely-dosable cannabis products for customers.

MEDIF key facts

Ticker symbol

MEDIF

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Barrie, ON, Canada

Country of incorporation

CA

Year of incorporation

2017

Employees

273

Estimated market cap

$23.70M (as of Apr 10, 2025)

Shares outstanding

415,138,973

Reporting standard

International Reporting: Toronto Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Medipharm Labs Corporation leadership

• David Pidduck — CEO
• Keith Graham Strachan — President
• Shelley Martin — Lead Director
• Greg Hunter — CFO
• Adegebo Ifeoluwa — Corporate Controller
• Wuraola Laly — Manager

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with M